Crossmark

Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification

Crossref DOI link: https://doi.org/10.1007/s00210-023-02510-9

Published Online: 2023-05-06

Published Print: 2023-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Ye https://orcid.org/0000-0001-7483-2027
Yan, Jiaoyan https://orcid.org/0000-0003-2967-8475
Huang, Jian https://orcid.org/0000-0002-1397-5670
Wu, Xiangyi https://orcid.org/0009-0004-3455-4607
Yuan, Yan https://orcid.org/0009-0001-0808-4996
Yuan, Yan https://orcid.org/0000-0003-3477-0209
Zhang, Shu https://orcid.org/0000-0001-8836-0745
Mo, Fei
License Information

Text and Data Mining valid from 2023-05-06

Version of Record valid from 2023-05-06
More Information

Article History

Received: 1 April 2023

Accepted: 21 April 2023

First Online: 6 May 2023

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below